Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15
Benzinga Newsdesk 1 month ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $13 to $15.
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $13 to $15.